{
  "chapter_title": "Business Activities",
  "section_title": "Geographical Market & Coverage",
  "description": "Key regions of operation and geographical exposure.",
  "questions": [
    {
      "question": "What are the primary geographic markets for Ion Beam Applications SA's products or services?",
      "queries": [
        {
          "query": "Ion Beam Applications SA market regions",
          "results": [
            {
              "text": "00% \n100% \nIon Beam Beijing Applications Co. Ltd. Beijing, China \n100% \n100% \nIBA RadioIsotopes France SAS \nLyon, France \n100% \n100% \nIBA Dosimetry Ltd. Schwarzenbruck, Germany \n100% \n100% \nIBA Dosimetry America Inc. Bartlett, USA \n100% \n100% \nIBA Proton Therapy Inc. Edgewood New York, USA \n100% \n100% \nIBA Industrial Inc. Edgewood New York, USA \n100% \n100% \nIBA USA Inc. Edgewood New York, USA \n100% \n100% \nIBA Particle Therapy Ltd.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "geographic coverage of Ion Beam Applications SA",
          "results": [
            {
              "text": "00% \n100% \nIon Beam Beijing Applications Co. Ltd. Beijing, China \n100% \n100% \nIBA RadioIsotopes France SAS \nLyon, France \n100% \n100% \nIBA Dosimetry Ltd. Schwarzenbruck, Germany \n100% \n100% \nIBA Dosimetry America Inc. Bartlett, USA \n100% \n100% \nIBA Proton Therapy Inc. Edgewood New York, USA \n100% \n100% \nIBA Industrial Inc. Edgewood New York, USA \n100% \n100% \nIBA USA Inc. Edgewood New York, USA \n100% \n100% \nIBA Particle Therapy Ltd.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "primary markets for Ion Beam Applications SA",
          "results": [
            {
              "text": "company \nincorporated and domiciled in Belgium. The \naddress of its registered office is Chemin du \nCyclotron, 3; B-1348 \nLouvain-la-Neuve, Belgium. Ion Beam Applications SA is the \nmother Company of the Group and the Ultimate \nParent. The Company is listed on the pan-European \nEuronext stock exchange (B-compartment) and \nis included in the BEL Mid Index. IBA publishes condensed half-yearly and \nannual consolidated financial statements which \nhave been prepared in accordance with IFRS \nas endorsed by EU.",
              "source": "",
              "score": 0.0
            }
          ]
        }
      ]
    },
    {
      "question": "How does Ion Beam Applications SA's geographical presence impact its credit risk and KYC requirements?",
      "queries": [
        {
          "query": "credit risk and KYC implications of Ion Beam Applications SA's geography",
          "results": [
            {
              "text": "2022), and unused overdraft \nfacilities in China. Credit facilities \nIBA SA has access to EUR 44.5 million (initially, EUR 67 million) syndicated credit facilities in the \nform of EUR 40 million revolving credit facilities \nmaturing in December 2024. The revolving \ncredit facilities remained undrawn as of \nDecember 31, 2023. In China, the CNY 35 million overdraft facility \n(borrower: Ion Beam Applications Co. Ltd) was \nmaintained for the same amount (undrawn). Covenant risk \nThe above-mentionned facilities are subject to \ncertain financial covenants.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "geographical exposure of Ion Beam Applications SA for credit risk",
          "results": [
            {
              "text": "2022), and unused overdraft \nfacilities in China. Credit facilities \nIBA SA has access to EUR 44.5 million (initially, EUR 67 million) syndicated credit facilities in the \nform of EUR 40 million revolving credit facilities \nmaturing in December 2024. The revolving \ncredit facilities remained undrawn as of \nDecember 31, 2023. In China, the CNY 35 million overdraft facility \n(borrower: Ion Beam Applications Co. Ltd) was \nmaintained for the same amount (undrawn). Covenant risk \nThe above-mentionned facilities are subject to \ncertain financial covenants.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "KYC considerations for Ion Beam Applications SA's global operations",
          "results": [
            {
              "text": "=== Page 199 ===\niba-worldwide.com\nContact IBA\nCorporate Communication\nTel. +32 10 47 58 90\nE-mail: communiation@iba-group.com\nIon Beam Applications, SA\nChemin du Cyclotron, 3\n1348 Louvain-la-Neuve, Belgium\nTel. +32 10 47 58 11 - Fax: +32 10 47 58 10\nRPM Nivelles - TVA: BE 428.750.985\nE-mail: info-worldwide@iba-group.com\nwww.iba-worldwide.com\nE.R. IBA SA, chemin du Cyclotron, 3\n1348 Louvain-la-Neuve, Belgium\nDesign & Production: www.thecrew.be",
              "source": "",
              "score": 0.0
            }
          ]
        }
      ]
    },
    {
      "question": "What are the key regional differences in demand, competition, or regulatory environments that affect Ion Beam Applications SA?",
      "queries": [
        {
          "query": "regional differences in demand and competition for Ion Beam Applications SA",
          "results": [
            {
              "text": "=== Page 17 ===\nAN EVEN FASTER GROWTH \nIN AMERICA AND ASIA\nUntil recently, reference sites for X-ray and electron beam \nindustrial sterilization were mostly concentrated in central \nEurope. Today, IBA Industrial sees a strong deployment of the \ntechnology in all regions of the world, with remarkable activity \nin the United States, Southeast Asia and China. IBA is currently \ndeploying a stronger regionalization plan in those areas where it \nis already present, including adding resources for installations \nand services, hubs for parts logistics, and third-party suppliers.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "geographic variations in regulations affecting Ion Beam Applications SA",
          "results": [
            {
              "text": "ions \ndiffer greatly from one country to another. Operational risks \nSale risk \nIn general, IBAs customers are diversified \n(public and private sector) and located on \nseveral continents. Each year the Company \ndepends on multiple orders, particularly for its \nproton therapy systems that are implemented \nover several financial years. One additional \norder or one order less, or changes in an order \nthat were not anticipated at the beginning of the \nyear, are characteristics of this field of business \nthat can have a significant impact over several \naccounting periods.",
              "source": "",
              "score": 0.0
            }
          ]
        },
        {
          "query": "impact of regional markets on Ion Beam Applications SA's credit risk",
          "results": [
            {
              "text": "ions \ndiffer greatly from one country to another. Operational risks \nSale risk \nIn general, IBAs customers are diversified \n(public and private sector) and located on \nseveral continents. Each year the Company \ndepends on multiple orders, particularly for its \nproton therapy systems that are implemented \nover several financial years. One additional \norder or one order less, or changes in an order \nthat were not anticipated at the beginning of the \nyear, are characteristics of this field of business \nthat can have a significant impact over several \naccounting periods.",
              "source": "",
              "score": 0.0
            }
          ]
        }
      ]
    }
  ]
}